Selective, Intrinsically Fluorescent Trk Modulating Probes.

Area of Science:

• Neuroscience
• Molecular Biology
• Medicinal Chemistry

Background:

• Neurotrophins (NTs) are crucial for neuronal development and survival, acting through Trk receptors.
• Developing selective small-molecule probes for Trk receptors (TrkA, TrkB, TrkC) is challenging due to difficulties in verifying Trk activation pathways.
• Existing probes lack inherent detectability, hindering their use in early-stage assays.

Purpose of the Study:

• To design and synthesize novel, easily detectable, low molecular mass probes for Trk receptors.
• To identify selective Trk receptor agonists or modulators with potential neuroprotective effects.
• To overcome limitations of current Trk receptor probes in terms of selectivity and detectability.

Main Methods:

• Design and synthesis of cyclo-organopeptide derivatives incorporating a BODIPY fluorophore.
• Utilized live-cell binding assays leveraging intrinsic fluorescence for Trk receptor activation screening.
• Evaluated selectivity of identified compounds across TrkA, TrkB, and TrkC receptors.
• Assessed neuroprotective effects of the developed probes.

Main Results:

• Successfully designed novel cyclo-organopeptide derivatives with intrinsic fluorescence.
• Identified compounds that selectively activate TrkA, TrkB, or TrkC receptors.
• Demonstrated that these probes exhibit neuroprotective effects.
• Established the utility of fluorescent probes for studying Trk receptor activity.

Conclusions:

• Developed novel, low molecular mass, fluorescent Trk-selective probes.
• These probes facilitate the study of Trk receptor activation and neurotrophin signaling.
• The identified compounds show potential for therapeutic applications in neuroprotection.